Related references
Note: Only part of the references are listed.Population pharmacokinetics of tolvaptan in healthy subjects and patients with hyponatremia secondary to congestive heart failure or hepatic cirrhosis
Scott A. Van Wart et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2013)
Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor
Dagmar Kubitza et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Rivaroxaban: A Review of its Use in the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation
Natalie J. Carter et al.
DRUGS (2013)
Population pharmacokinetics of bisoprolol in patients with chronic heart failure
Valentina N. Nikolic et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Population pharmacokinetics of carvedilol in patients with congestive heart failure
Valentina N. Nikolic et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Pharmacokinetics and Pharmacodynamics of Oral Tolvaptan Administered in 15-to 60-mg Single Doses To Healthy Korean Men
SoJeong Yi et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2012)
Hepatocellular Necrosis, Fibrosis and Microsomal Activity Determine the Hepatic Pharmacokinetics of Basic Drugs in Right-Heart-Failure-Induced Liver Damage
Peng Li et al.
PHARMACEUTICAL RESEARCH (2012)
Clinical Pharmacokinetics of Metformin
Garry G. Graham et al.
CLINICAL PHARMACOKINETICS (2011)
Determination of Digoxin Clearance in Japanese Elderly Patients for Optimization of Drug Therapy A Population Pharmacokinetics Analysis Using Nonlinear Mixed-Effects Modelling
Miho Yukawa et al.
DRUGS & AGING (2011)
Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment
Barry A. Borlaug et al.
EUROPEAN HEART JOURNAL (2011)
Angiotensin Receptor Blockers: Pharmacology, Efficacy, and Safety
Addison A. Taylor et al.
JOURNAL OF CLINICAL HYPERTENSION (2011)
Population Pharmacokinetic Investigation of Digoxin in Japanese Infants and Young Children
Miho Yukawa et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Pharmacokinetics and pharmacodynamics of rivaroxaban and its effect on biomarkers of hypercoagulability in patients with chronic heart failure
Mihai Gheorghiade et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2011)
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
New drugs vs. old concepts: A fresh look at antiarrhythmics
Jerome Thireau et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Population pharmacokinetic model of digoxin in older Chinese patients and its application in clinical practice
Xiao-dan Zhou et al.
ACTA PHARMACOLOGICA SINICA (2010)
Population Pharmacokinetics of R- and S-Carvedilol in Japanese Patients with Chronic Heart Failure
Masako Saito et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2010)
Fluvoxamine pharmacokinetics in healthy elderly subjects and elderly patients with chronic heart failure
Rocco Orlando et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor
Dagmar Kubitza et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
A Comprehensive Review of the Loop Diuretics: Should Furosemide Be First Line?
Kurt A. Wargo et al.
ANNALS OF PHARMACOTHERAPY (2009)
Impact of Infectious and Inflammatory Disease on Cytochrome P450-Mediated Drug Metabolism and Pharmacokinetics
E. T. Morgan
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Pharmacokinetics of R- and S-Carvedilol in routinely treated Japanese patients with heart failure
Isao Horiuchi et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)
Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure
Stefanie Albers et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Modulation of Cardiac and Hepatic Cytochrome P450 Enzymes During Heart Failure
Ayman El-Kadi et al.
CURRENT DRUG METABOLISM (2008)
Erhöhte Flecainid-Plasmakonzentrationen bei Herzinsuffizienz*
J. Nitsch et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2008)
Collagen accumulation and dysfunctional mucosal barrier of the small intestine in patients with chronic heart failure
Gregory P. Arutyunov et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2008)
Altered intestinal function in patients with chronic heart failure
Anja Sandek et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the cocktail approach
U. Fuhr et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Population pharmacokinetics of s(-)-carvedilol in healthy volunteers after administration of the immediate-release (IR) and the new controlled-release (CR) dosage forms of the racemate
Ahmed A. Othman et al.
AAPS JOURNAL (2007)
A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan
Toshihide Takagi et al.
MOLECULAR PHARMACEUTICS (2006)
Effect of congestive heart failure on mexiletine pharmacokinetics in a Japanese population
Mariko Kobayashi et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
The suitability of an in situ perfusion model for permeability determinations: Utility for BCS class I biowaiver requests
Jae-Seung Kim et al.
MOLECULAR PHARMACEUTICS (2006)
Pharmacokinetic profile of controlled-release carvedilol in patients with left ventricular dysfunction associated with chronic heart failure or after myocardial infarction
Milton Packer et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Effect of CYP2D6*10 on the pharmacokinetics of R- and S-carvedilol in healthy Japanese volunteers
M Honda et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2005)
Pharmacokinetics of eplerenone after single and multiple dosing in subjects with and without renal impairment
WR Ravis et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling:: theophylline and midazolam as model drugs
S Björkman
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Clinical pharmacokinetics of Losartan
DA Sica et al.
CLINICAL PHARMACOKINETICS (2005)
Effect of hypoxia on cytochrome P450 activity and expression
C Fradette et al.
CURRENT DRUG METABOLISM (2004)
Nonlinear mixed effects model analysis of the pharmacokinetics of metoprolol in routinely treated Japanese patients
M Taguchi et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2004)
Pharmacokinetics and metabolism of [14C]eplerenone after oral administration to humans
CS Cook et al.
DRUG METABOLISM AND DISPOSITION (2003)
Altered pharmacokinetics and excessive hypotensive effect of candesartan in a patient with the CYP2C9*1/*3 genotype
S Uchida et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Carvedilol - A review of its use in chronic heart failure
GM Keating et al.
DRUGS (2003)
Pharmacokinetics of multiple doses of valsartan in patients with heart failure
PP Prasad et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2002)
Pharmacoepidemiologic detection of calcium channel blocker-induced change on digoxin clearance using multiple trough screen analysis
F Suematsu et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2002)
Pharmacokinetics of irbesartan are not altered in special populations
MR Marino et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2002)
Carvedilol therapy in pediatric patients with congestive heart failure:: A study investigating clinical and pharmacokinetic parameters
S Läer et al.
AMERICAN HEART JOURNAL (2002)
Candesartan cilexetil - An update of its use in essential hypertension
SE Easthope et al.
DRUGS (2002)
Clinical pharmacokinetics of candesartan
CH Gleiter et al.
CLINICAL PHARMACOKINETICS (2002)
Pharmacodynamics and pharmacokinetics of omapatrilat in heart failure
JB Kostis et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
The pharmacokinetics and pharmacodynamics of irbesartan in heart failure
JB Kostis et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Oral bioavailability and disposition of [14C]omapatrilat in healthy subjects
BK Malhotra et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Pharmacokinetic-pharmacodynamic model for perindoprilat regional haemodynamic effects in healthy volunteers and in congestive heart failure patients
E Bellissant et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Population pharmacokinetics of digoxin in Japanese patients - A 2-compartment pharmacokinetic model
E Yukawa et al.
CLINICAL PHARMACOKINETICS (2001)
Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial
JL Rouleau et al.
LANCET (2000)
Steady-state pharmacokinetics of carvedilol and its enantiomers in patients with congestive heart failure
D Tenero et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Share Paper
